What's left to say about Cel Sci Corp. (CVM)? That company and its stock have received a heck of a lot of press over the past couple of weeks and I maintain my opinion that - in my opinion - the stock will pay off based on the potential of Multikine; and as I've said before, the LEAPS swine flu potential is icing on the cake.
Additionally, the company is very likely to pull in some fairly significant revenue from rentees who are expected to rent space in the new facility. It could be assumed that any money raised from the rent will help fund the Multikine Phase III trial, which I expect will get underway in the not-so-distant future.
I'm basing that opinion on previous released information and the fact that the Cel Sci website has recently added a number of job listings - all having to do with vaccine manufacturing.
In my opinion, the job listings are a good indicator that Cel Sci is in fact preparing for the Multikine Phase III trial - contrary to what the naysayers have been saying over the past couple of weeks.
As always, CVM is a stock to watch and buy the dips if you're still accumulating.
Disclosure: VFC is long CVM.